PAYX 47.57 Paychex Inc $PAYX Hit a 52 week high of 48.20

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
PAYX 47.57 Paychex Inc $PAYX Hit a 52 week high of 48.20 Closing the day 11/06/14 at 47.57 -0.20 -0.42% With a day low of 47.53 and a total volume of 3,352,898.

PAYX Recent Posts: http://investorshangout.com/Paychex-Inc-PAYX-55051/

PAYX Paychex Inc Recent Headline News

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 250.38 (+2.47), LMT: 189.88 (+0.15), XOM: 96.26 (+1.19), ILMN: 189.87 (+3.50), AKS: 6.14 (-0.09), KORS: 72.31 (-0.09), PAYX: 47.57 (-0.20), RIG: 29.92 (+1.03), EOG: 98.97 (+2.87), COST: 137.09 (+0.59), TWTR: 40.84 (+0.47), OXY: 86.40 (-0.07), KO: 42.29 (-0.02), SEAS: 18.84 (+0.14), TMO: 118.91 (+0.36), NUE: 53.48 (+0.42), TRIP: 74.00 (+2.05), DISCA: 32.90 (-1.57), CHUY: 22.00 (+1.32), LB: 76.35 (+1.35), GEO: 40.64 (+0.74), ESV: 40.50 (+0.49), MPC: 93.13 (+2.42), BAX: 71.60 (+0.70), MRK: 59.26 (-0.31), EXPE: 84.06 (+1.01), STI: 39.82 (+0.22)

Paychex Rises 1.10% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Nov 05, 5:14PM CST
Paychex (NASDAQ AYX) traded in a range yesterday that spanned from a low of $47.38 to a high of $47.88. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $47.62 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PAYX: 47.57 (-0.20)

Look for Shares of Paychex to Potentially Pullback after Yesterday's 1.10% Rise
Comtex SmarTrend(R) - Wed Nov 05, 5:13PM CST
Paychex (NASDAQ AYX) traded in a range yesterday that spanned from a low of $47.38 to a high of $47.88. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $47.62 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PAYX: 47.57 (-0.20)

3 Reasons Why Automatic Data Processing Is a Top Dividend Stock
Dan Caplinger, The Motley Fool - Motley Fool - Wed Nov 05, 1:30PM CST
Source: ADP. Many dividend investors focus exclusively on high yields from their stocks, choosing to let lower-yielding dividend payers go untouched. Yet that would lead you to leave out stocks like Automatic Data Processing , which has a nearly...
PAYX: 47.57 (-0.20), ADP: 84.75 (+0.45), INTU: 89.13 (+0.40)

Paychex | IHS Small Business Jobs Index Continues Trend of Employment Growth for Small Businesses in October
Business Wire - Tue Nov 04, 7:30AM CST
While the Paychex | IHS Small Business Jobs Index grew 0.23 percent in the past 12 months, the national index remained even for October, coming in at 100.84. Showing no change, the rate of job creation seen in September was consistent through October. Though down 0.25 percent during the past three months, the national index is still in a position of strength, well above the baseline of 100. Employment growth in the Central regions put the West North Central region at the top of the regional index, while Washington took over the lead among the states, and Dallas reclaimed the top spot among metro areas.
PAYX: 47.57 (-0.20), IHS: 129.75 (+0.05)

Paychex Shares Up 11.8% Since SmarTrend's Buy Recommendation (PAYX)
Comtex SmarTrend(R) - Mon Nov 03, 4:55PM CST
SmarTrend identified an Uptrend for Paychex (NASDAQ AYX) on September 3rd, 2014 at $42.10. In approximately 2 months, Paychex has returned 11.79% as of today's recent price of $47.06.
PAYX: 47.57 (-0.20)

AppDynamics Business Momentum Accelerates in Fiscal Q3 -- Annualized Bookings Run-Rate Surpasses $160 Million
Marketwired - Mon Nov 03, 7:03AM CST
APPSPHERE -- AppDynamics, the application intelligence leader for software-defined businesses, today announced accelerated momentum across every aspect of its business. In Q3 FY15, ending October 31, trailing 12-month revenue grew more than 200 percent; trailing 12-month bookings grew more than 115 percent, and the company's annualized bookings run-rate, based on fiscal Q3 results, surpassed $160 million. Additionally, during the quarter the company concluded a record number of nine deals greater than one million dollars. By every metric the quarter's results underscore the continued and rapid rise in demand for application intelligence, and continued emergence of AppDynamics as the leader in the category.
PAYX: 47.57 (-0.20), KR: 57.76 (+0.25)

Data Processing and Outsourced Services Stocks Technical Review - Xerox, Vantiv, Paychex, Computer Sciences, and Fidelity National Information Services
PR Newswire - Fri Oct 31, 8:20AM CDT
Investor-Edge has initiated coverage on the following equities: Xerox Corporation (NYSE: XRX), Vantiv Inc. (NYSE: VNTV), Paychex Inc. (NASDAQ: PAYX), Computer Sciences Corporation (NYSE: CSC), and Fidelity National Information Services Inc. (NYSE: FIS). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, October 30, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,195.42, up 1.30% and the NASDAQ Composite closed at 4,566.14, up 0.37%. The S&P 500 finished the session 0.62% higher at 1,994.65. During the trading session, nine out of ten sectors finished on a higher note. The S&P 500 Information Technology Sector Index ended the day at 659.28, up 0.23%, with the index gaining 12.61% on YTD basis. Register for your complimentary reports on these five stocks at:
FIS: 58.92 (+0.13), PAYX: 47.57 (-0.20), CSC: 59.69 (-0.69), XRX: 13.30 (+0.14), VNTV: 30.50 (+0.23)

Vistaprint Beats Q1 Earnings on Operational Excellence - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:00AM CDT
Vistaprint N.V. (VPRT) reported solid first-quarter fiscal 2015 results as revenues and adjusted earnings improved year over year due to the successful implementation of major pricing and marketing changes.
PAYX: 47.57 (-0.20), EXPO: 79.94 (+0.76), VPRT: 66.49 (+0.71), III: 4.55 (+0.01)

Automatic Data Processing (ADP) Tops Q1 Earnings, Sales Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 9:44AM CDT
Automatic Data Processing Inc. (ADP) reported first-quarter fiscal 2015 earnings from continuing operations of 62 cents per share, which surpassed the Zacks Consensus Estimate.
PAYX: 47.57 (-0.20), ADP: 84.75 (+0.45), EFX: 77.54 (+1.11), TNET: 29.26 (-0.24)

Will Automatic Data Processing (ADP) Miss Earnings? (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 1:59PM CDT
ADP has posted an average positive earnings surprise of 0.83% over the past four quarters.
PAYX: 47.57 (-0.20), ADP: 84.75 (+0.45), FB: 75.26 (+0.43), INVN: 15.67 (-0.28), EFX: 77.54 (+1.11)

Ex-Dividend Reminder: Paychex, Celanese and EnLink Midstream Partners
DividendChannel.com - Tue Oct 28, 9:30AM CDT
Looking at the universe of stocks we cover at Dividend Channel, on 10/30/14, Paychex Inc , Celanese Corp , and EnLink Midstream Partners LP will all trade ex-dividend for their respective upcoming dividends. Paychex Inc will pay its quarterly...
PAYX: 47.57 (-0.20)

Will Automatic Data Processing (ADP) Miss Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 6:30PM CDT
Automatic Data Processing, Inc. (ADP) is set to report fourth quarter 2014 results on Oct 29.
PAYX: 47.57 (-0.20), ADP: 84.75 (+0.45), FB: 75.26 (+0.43), INVN: 15.67 (-0.28), EFX: 77.54 (+1.11)

Top Dividend Payers Thrive Amid New Market Uptrend
at Investor's Business Daily - Fri Oct 24, 4:33PM CDT
Microsoft and other top dividend stocks have fared well since a new market uptrend that began last week. Microsoft (MSFT), Paychex (PAYX), Teco Energy (TE) and Medical Properties Trust (MPW) appeared in the IBD Income Investor column before the Oct....
MPW: 13.53 (-0.08), TE: 19.72 (-0.43), PAYX: 47.57 (-0.20), HCP: 43.12 (-1.37), MSFT: 48.70 (+0.84)

Paychex Small Business Snapshot: Majority of Startup Businesses are Comfortable Using Technology
Business Wire - Thu Oct 23, 12:57PM CDT
Paychex, Inc., a leading provider of payroll, human resource, insurance, and benefits outsourcing solutions for small- to medium-sized businesses, today released the results of its latest Paychex Small Business Snapshot, which shows owners of recently formed small businesses are comfortable using technology and are taking advantage of time-saving mobility.
PAYX: 47.57 (-0.20)

Nielsen's (NLSN) Q3 Earnings and Revenues Increase Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:33PM CDT
Nielsen Holdings N.V. (NLSN) reported adjusted third-quarter 2014 earnings of 66 cents per share which came ahead of the Zacks Consensus Estimate as well as the year-ago quarter.
PAYX: 47.57 (-0.20), NLSN: 43.34 (+1.06), MRVL: 13.37 (-0.32), SUNE: 18.37 (-0.51)

You Can Find Deep Value in the Market by Eliminating Emotion
at The Street - Thu Oct 23, 10:34AM CDT
Here are three stocks to consider.
PAYX: 47.57 (-0.20), ADP: 84.75 (+0.45), EIG: 21.56 (-0.11)

SurePayroll Small Business Scorecard(R): SMBs Express Biggest Concerns Heading Into Election
Marketwired - Wed Oct 22, 5:02AM CDT
Heading into November's mid-term elections, small business owners with primarily 1-10 employees discussed the concerns they would most like Congress to address in October's SurePayroll Small Business Scorecard® optimism survey. Their confidence appears to be dipping as they await to see how certain issues are handled.
PAYX: 47.57 (-0.20)

Paychex Offers Stable Dividends As It Nears Buy Point
at Investor's Business Daily - Tue Oct 21, 4:48PM CDT
If there's one word to describe Paychex, it's stability. Paychex's (PAYX) three-year earnings stability factor is 1 on a scale of 0 (most stable) to 99 (least stable). The stock price has also been stable -- slipping 2% this year but rising 6% over...
PAYX: 47.57 (-0.20)

Paychex Declares Quarterly Dividend
Business Wire - Wed Oct 15, 6:24AM CDT
Today the Board of Directors of Paychex, Inc. (NASDAQ AYX) declared a regular quarterly dividend of $.38 per share payable November 20, 2014 to shareholders of record November 3, 2014.
PAYX: 47.57 (-0.20)

Paychex Inc. (PAYX) Stock Research Links

PAYX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Iceland Seafood International hf Announces Successful Bill Auction

Updated Category News Views 171

Iceland Seafood International hf's Successful Auction Iceland Seafood International hf. has recently completed an offering of 3-month bills under the new series ICESEA 25 0304. This significant milestone reflects the company's ongoing efforts to strengthen its financial position and enhance its market presence. Details of the Bill Auction The total offers for the bills...

Continue Reading
Prolong Pharmaceuticals Showcases PP-007 in Innovative Stroke Study

Updated Category News Views 194

Prolong Pharmaceuticals Highlights Phase 1 Results for Acute Ischemic Stroke Treatment Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical firm, is making waves in the medical community with its recent announcement regarding the preliminary data from the HEMERA-1 trial. This significant study looks into the effects of their lead asset, PP-007, in treating...

Continue Reading
Investors Urged to Join Class Action Against Verve Therapeutics

Updated Category News Views 89

Investors: Consider Joining the Verve Therapeutics Class Action Robbins LLP, a shareholder-rights law firm, is reminding investors about an important window to act in the class action against Verve Therapeutics, Inc. (NASDAQ: VERV). The lawsuit covers individuals and entities that bought or otherwise acquired Verve securities during a defined time frame. Verve is a...

Continue Reading
Top Dividend Stocks for Passive Income Success

Updated Category News Views 246

Building Passive Income Through Smart Investments Creating passive income is a crucial element of a successful early retirement plan. Establishing various sources of passive income is important to reduce the pressure of depending solely on active work for financial support. A key aspect of this strategy is investing in companies known for their above-average dividends,...

Continue Reading
Temperature Monitoring Devices Market Expected to Surge

Updated Category News Views 61

The temperature monitoring devices market experienced a notable surge back in 2024, with projections estimating a compound annual growth rate (CAGR) of 4.5% through to 2034. By the end of that forecast period, sales revenue was set to hit around USD 5.3 billion—a clear indicator of robust expansion in this critical sector. Market Dynamics: Diverse Applications Across...

Continue Reading